These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 32680781

  • 21. Association between trajectories of statin adherence and subsequent cardiovascular events.
    Franklin JM, Krumme AA, Tong AY, Shrank WH, Matlin OS, Brennan TA, Choudhry NK.
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1105-13. PubMed ID: 25903307
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The OPTIMIZE trial: Rationale and design of a randomized controlled trial of motivational enhancement therapy to improve adherence to statin medication.
    Rash JA, Lavoie KL, Sigal RJ, Campbell DJ, Manns BJ, Tonelli M, Campbell TS.
    Contemp Clin Trials; 2016 Jul; 49():47-56. PubMed ID: 27282119
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study.
    Marcum ZA, Walker RL, Jones BL, Ramaprasan A, Gray SL, Dublin S, Crane PK, Larson EB.
    BMC Geriatr; 2019 Feb 14; 19(1):41. PubMed ID: 30764775
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Adherence trajectories of buprenorphine therapy among pregnant women in a large state Medicaid program in the United States.
    Lo-Ciganic WH, Donohue JM, Kim JY, Krans EE, Jones BL, Kelley D, James AE, Jarlenski MP.
    Pharmacoepidemiol Drug Saf; 2019 Jan 14; 28(1):80-89. PubMed ID: 30192041
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Who benefits from fixed-dose combinations? Two-year statin adherence trajectories in initiators of combined amlodipine/atorvastatin therapy.
    Schaffer AL, Buckley NA, Pearson SA.
    Pharmacoepidemiol Drug Saf; 2017 Dec 14; 26(12):1465-1473. PubMed ID: 29067759
    [Abstract] [Full Text] [Related]

  • 37. Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design.
    Boulmpou A, Kartas A, Farmakis I, Zafeiropoulos S, Nevras V, Papadimitriou I, Tampaki A, Vlachou A, Lillis L, Koutsakis A, Karvounis H, Giannakoulas G.
    Hellenic J Cardiol; 2019 Dec 14; 60(4):249-253. PubMed ID: 30352291
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Impact of a telephonic outreach program on medication adherence in Medicare Advantage Prescription Drug (MAPD) plan beneficiaries.
    Park H, Adeyemi A, Wang W, Roane TE.
    J Am Pharm Assoc (2003); 2017 Dec 14; 57(1):62-66.e2. PubMed ID: 27777074
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.